nootropic/coffee Evidence Grade B 8 Citations

V-NEUROKAFE

Arabica Coffee, Bacopa Monnieri 300mg, Phosphatidylserine 100mg, Ginkgo Biloba 120mg

📋 Overview

V-NEUROKAFE is a nootropic-enhanced coffee formula combining the acute alertness of Arabica caffeine with three clinically studied cognitive ingredients -€” Bacopa Monnieri, Phosphatidylserine, and Ginkgo Biloba -€” targeting memory consolidation, mental processing speed, and sustained attention. The combination is best suited for knowledge workers, students, and older adults seeking both immediate and long-term cognitive enhancement. Evidence is strongest for Bacopa Monnieri and Phosphatidylserine, with Grade B support from multiple randomized controlled trials. ---

Key Ingredients

  • Arabica Coffee
  • Bacopa Monnieri 300mg
  • Phosphatidylserine 100mg
  • Ginkgo Biloba 120mg

What Does The Research Say?

The backbone of V-NEUROKAFE's acute cognitive effect is caffeine from Arabica Coffee, one of the most extensively studied psychoactive compounds in human nutrition. Caffeine exerts its primary effects by antagonizing adenosine A1 and A2A receptors in the brain, reducing perceived fatigue and increasing dopaminergic and noradrenergic signaling. A landmark 2004 meta-analysis by Einöther and Giesbrecht confirmed that caffeine doses of 40-€“300mg significantly improve attention, vigilance, and reaction time in healthy adults (PMID: 14759755). Arabica beans typically deliver a smoother caffeine curve with lower chlorogenic acid bitterness, and studies have associated regular coffee consumption with reduced risk of neurodegenerative disease, including a 2002 review in JAMA noting a 32% lower Parkinson's risk with habitual intake (PMID: 11790213).

Bacopa Monnieri at 300mg per serving sits squarely within the dose range validated by clinical trials for memory enhancement. A rigorous 12-week double-blind RCT by Roodenrys et al. (2002) published in Neuropsychopharmacology enrolled 76 adults aged 40-€“65 and found that 300mg of standardized Bacopa extract (55% bacosides) significantly improved verbal learning rate and delayed recall compared to placebo, with the most robust effects appearing after week 8-€“12 of supplementation (PMID: 12093601). A subsequent meta-analysis by Kongkeaw et al. (2014) in the Journal of Ethnopharmacology pooled 9 RCTs and confirmed Bacopa's consistent benefit on free recall memory, with statistically significant effect sizes across multiple cognitive domains (PMID: 24252493).

Phosphatidylserine (PS) at 100mg provides direct structural and functional support to neuronal cell membranes, a mechanism with particularly strong evidence in aging populations. A pivotal multi-center double-blind trial published in 1991 by Crook et al. in Neurology administered 300mg/day PS to 149 patients with age-associated memory impairment over 12 weeks, finding significant improvements in learning, recall, and global clinical assessment scores compared to placebo, with treated patients performing 15% better on memory tasks (PMID: 1678027). More recently, a 2010 RCT by Richter et al. in Journal of Clinical Biochemistry and Nutrition demonstrated that even 100mg PS daily for 6 months improved memory recall and attention in elderly subjects with memory complaints, validating that the dose in V-NEUROKAFE is clinically relevant (PMID: 20190010).

Ginkgo Biloba at 120mg rounds out the formula with robust cerebrovascular and antioxidant actions. The EGb 761 standardized extract used in most trials (24% flavone glycosides, 6% terpene lactones) has been tested in dozens of RCTs. A 2010 Cochrane-informed systematic review confirmed that 120-€“240mg Ginkgo daily produced significant improvements in cognitive function and activities of daily living in patients with mild-to-moderate dementia, with benefits reaching statistical significance in attention and memory subscales (PMID: 20091579). In healthy younger adults, a 2000 trial by Mix and Crimson in Human Psychopharmacology showed that a single 120mg dose of Ginkgo significantly enhanced speed of attention at 2.5 and 6 hours post-dose, suggesting both acute and chronic utility for this ingredient (PMID: 10890298).

---

⚙️ Mechanism of Action

Caffeine blocks adenosine A1/A2A receptors to acutely elevate dopamine, norepinephrine, and acetylcholine availability, while Bacopa Monnieri's active bacosides enhance synaptic signal transmission by modulating acetylcholinesterase activity and upregulating BDNF expression, supporting hippocampal neuroplasticity. Phosphatidylserine integrates into neuronal phospholipid bilayers to maintain membrane fluidity and voltage-gated ion channel function, facilitating more efficient neurotransmitter release and receptor binding. Ginkgo Biloba's ginkgolides inhibit platelet-activating factor (PAF), reduce oxidative stress via flavonoid free-radical scavenging, and increase cerebral blood flow, collectively amplifying nutrient and oxygen delivery to neurons and synergizing with the upstream nootropic actions of the other three ingredients. ---

PubMed Citations

Frequently Asked Questions

What is V-NEUROKAFE used for?
V-NEUROKAFE is formulated to support working memory, processing speed, attention, and resistance to mental fatigue. Clinical trials on its ingredients show statistically significant improvements in verbal recall (Bacopa, PMID 12093601), memory task performance (Phosphatidylserine, PMID 1678027), speed of attention (Ginkgo, PMID 10890298), and sustained vigilance (caffeine, PMID 14759755). It is particularly relevant for adults experiencing age-related cognitive slowdown, high cognitive workload professionals, and students during periods of intensive learning.
How long does it take to see results from V-NEUROKAFE?
Acute effects from caffeine and Ginkgo Biloba are detectable within 1–2.5 hours of consumption, as demonstrated in attention and reaction-time studies. Bacopa Monnieri requires consistent daily use for 8–12 weeks before peak memory-enhancement effects are realized, as shown in the Roodenrys 2002 RCT (PMID 12093601). Phosphatidylserine shows measurable cognitive improvements within 6–12 weeks of daily supplementation at clinical doses (PMID 20190010). Users should expect a two-phase experience: immediate alertness and focus within the first hour, followed by compounding memory benefits over 2–3 months of regular use.
What is the optimal dose of Bacopa Monnieri?
The majority of well-designed RCTs use 300mg/day of a standardized extract containing 45–55% bacosides — exactly the dose in V-NEUROKAFE. The Kongkeaw 2014 meta-analysis (PMID 24252493) confirmed that this dose range produced consistent, statistically significant improvements across free recall, learning rate, and cognitive processing measures. Some trials have used 450mg without additional benefit, suggesting 300mg represents a clinically effective and cost-efficient dose. It should be taken consistently rather than acutely, as bacosides require time to accumulate in neural tissue.
Are there any side effects or safety concerns?
All four ingredients in V-NEUROKAFE have well-characterized safety profiles at the doses provided. Bacopa Monnieri can cause mild gastrointestinal discomfort (nausea, increased bowel motility) in approximately 10–15% of users, which is typically mitigated by taking it with food. Phosphatidylserine is generally well tolerated; the Crook 1991 trial (PMID 1678027) reported no significant adverse events in 149 subjects over 12 weeks. Ginkgo Biloba at 120mg has a rare but documented interaction with anticoagulant medications (warfarin, aspirin) due to its PAF-inhibiting activity, and individuals on blood thinners should consult a physician. Caffeine intake should be monitored cumulatively across the day to avoid exceeding 400mg total daily intake as per FDA guidance.
Can V-NEUROKAFE be combined with other supplements?
V-NEUROKAFE stacks well with omega-3 fatty acids (DHA specifically), which further support neuronal membrane integrity and may enhance Phosphatidylserine absorption. Lion's Mane Mushroom is a complementary addition for nerve growth factor (NGF) stimulation without interaction risk. Users should exercise caution when combining with additional stimulants such as pre-workout formulas containing high-dose caffeine, as cumulative intake can cause anxiety, elevated heart rate, or disrupted sleep. Ginkgo's mild anticoagulant effect means it should not be combined with high-dose fish oil (>3g EPA/DHA) or pharmaceutical blood thinners without medical supervision.
Who should take V-NEUROKAFE?
Research points most strongly to benefit in three populations: (1) adults aged 40–65 experiencing age-associated memory impairment, supported by the Crook 1991 PS trial (PMID 1678027) and Roodenrys Bacopa trial (PMID 12093601); (2) healthy younger adults and students requiring sustained attention during demanding cognitive tasks, supported by caffeine and Ginkgo acute-dose studies; and (3) professionals in high-cognitive-load environments seeking both immediate performance and long-term neuroprotection. It is not recommended for pregnant or breastfeeding women, individuals sensitive to caffeine, or those on anticoagulant therapy without medical clearance. ---

Ready to Try V-NEUROKAFE?

Experience the evidence-backed benefits of this premium supplement formula.

Shop at Vital Health Global →

Affiliate link · We may earn a commission

V-LOVKAFE

S-BALANCE

V-NRGY
⚠️ Medical Disclaimer This content is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any supplement regimen. Individual results may vary. These statements have not been evaluated by the FDA.